Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
Barcellini A, Charalampopoulou A, De Cecco L, Fodor A, Rabaiotti E, Candotti G, Secondino S, Facoetti A, Locati LD, Pignata S, Orlandi E, Mangili G. Barcellini A, et al. Among authors: fodor a. Life (Basel). 2022 Dec 20;13(1):6. doi: 10.3390/life13010006. Life (Basel). 2022. PMID: 36675955 Free PMC article. Review.
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.
Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D'Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M, Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G. Macchia G, et al. Among authors: fodor a. Oncologist. 2020 Feb;25(2):e311-e320. doi: 10.1634/theoncologist.2019-0309. Epub 2019 Oct 10. Oncologist. 2020. PMID: 32043791 Free PMC article.
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy?
Barcellini A, Mangili G, Fodor A, Secondino S, Zerbetto F, Charalampopoulou A, Pignata S, Orlandi E, Bergamini A. Barcellini A, et al. Among authors: fodor a. Crit Rev Oncol Hematol. 2023 Jan;181:103889. doi: 10.1016/j.critrevonc.2022.103889. Epub 2022 Nov 26. Crit Rev Oncol Hematol. 2023. PMID: 36503888 Review.
Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).
Perrucci E, Macchia G, Cerrotta A, Andrulli AD, Autorino R, Barcellini A, Campitelli M, Corrao G, Costantini S, De Sanctis V, Di Muzio J, Epifani V, Ferrazza P, Fodor A, Garibaldi E, Laliscia C, Lazzari R, Magri E, Mariucci C, Pace MP, Pappalardi B, Pastorino A, Piccolo F, Scoglio C, Surgo A, Titone F, Tortoreto F, De Felice F, Aristei C. Perrucci E, et al. Among authors: fodor a. Radiol Med. 2024 Sep;129(9):1329-1351. doi: 10.1007/s11547-024-01844-5. Epub 2024 Aug 28. Radiol Med. 2024. PMID: 39198369 Free PMC article.
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer.
Macchia G, Cilla S, Pezzulla D, Campitelli M, Laliscia C, Lazzari R, Draghini L, Fodor A, D'Agostino GR, Russo D, Balcet V, Ferioli M, Vicenzi L, Raguso A, Di Cataldo V, Perrucci E, Borghesi S, Ippolito E, Gentile P, De Sanctis V, Titone F, Delle Curti CT, Huscher A, Gambacorta MA, Ferrandina G, Morganti AG, Deodato F. Macchia G, et al. Among authors: fodor a. Gynecol Oncol. 2024 May;184:16-23. doi: 10.1016/j.ygyno.2024.01.023. Epub 2024 Jan 24. Gynecol Oncol. 2024. PMID: 38271773
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study.
Nicosia L, Franceschini D, Perrone-Congedi F, Molinari A, Gerardi MA, Rigo M, Mazzola R, Perna M, Scotti V, Fodor A, Iurato A, Pasqualetti F, Gadducci G, Chiesa S, Niespolo RM, Bruni A, Cappelli A, D'Angelo E, Borghetti P, Di Marzo A, Ravasio A, De Bari B, Sepulcri M, Aiello D, Mortellaro G, Sangalli C, Franceschini M, Montesi G, Aquilanti FM, Lunardi G, Valdagni R, Fazio I, Scarzello G, Vavassori V, Maranzano E, Maria Magrini S, Arcangeli S, Gambacorta MA, Valentini V, Paiar F, Ramella S, Di Muzio NG, Loi M, Jereczek-Fossa BA, Casamassima F, Osti MF, Scorsetti M, Alongi F. Nicosia L, et al. Among authors: fodor a. Clin Transl Radiat Oncol. 2022 Dec 20;39:100568. doi: 10.1016/j.ctro.2022.100568. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2022. PMID: 36935855 Free PMC article.
Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study.
Di Muzio NG, Fodor A, Noris Chiorda B, Broggi S, Mangili P, Valdagni R, Dell'Oca I, Pasetti M, Deantoni CL, Chiara A, Berardi G, Briganti A, Calandrino R, Cozzarini C, Fiorino C. Di Muzio NG, et al. Among authors: fodor a. Clin Oncol (R Coll Radiol). 2016 Aug;28(8):490-500. doi: 10.1016/j.clon.2016.02.005. Epub 2016 Mar 5. Clin Oncol (R Coll Radiol). 2016. PMID: 26961088 Clinical Trial.
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis.
Valeriani M, Detti B, Fodor A, Caini S, Borghesi S, Trippa F, Triggiani L, Bruni A, Russo D, Saldi S, Di Staso M, Francolini G, Lancia A, Marinelli L, Di Muzio N, Aristei C, Livi L, Magrini SM, Ingrosso G. Valeriani M, et al. Among authors: fodor a. Radiol Med. 2022 Jan;127(1):108-116. doi: 10.1007/s11547-021-01424-x. Epub 2021 Nov 8. Radiol Med. 2022. PMID: 34748151
371 results